Daniel Rodriguez (D Rodriguez, Daniel Rodriguez Gutierrez)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Newly Diagnosed

Fluorescence Imaging

Top Venues

Journal of magnetic resonance imaging : JMRI

Clinical cancer research : an official journal of the American Association for Cancer Research

AJNR. American journal of neuroradiology

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Rodriguez, Raphael Calmon, Esther Sanchez Aliaga, Daniel Warren, Monika Warmuth-Metz, Chris Jones, Alan Mackay, Pascale Varlet, Marie-Cécile Le Deley, Darren R Hargrave, Adela Cañete Nieto, Maura Massimino, Amedeo A Azizi, Frank Saran, Gudrun Zahlmann, Josep Garcia, Gilles Vassal, Jacques Grill, Andrew C Peet, Robert A Dineen, Paul S Morgan, Timothy Jaspan
MRI and Molecular Characterization of Pediatric High-Grade Midline Thalamic Gliomas: The HERBY Phase II Trial. Radiology 304 (1) (2022)
Daniel Rodriguez, Chris Jones, Pascale Varlet, Alan Mackay, Daniel Warren, Monika Warmuth-Metz, Esther Sánchez Aliaga, Raphael Calmon, Darren R Hargrave, Adela Cañete, Maura Massimino, Amedeo A Azizi, Marie-Cécile Le Deley, Frank Saran, Raphael F Rousseau, Gudrun Zahlmann, Josep Garcia, Gilles Vassal, Jacques Grill, Paul S Morgan, Timothy Jaspan
Radiological Evaluation of Newly Diagnosed Non-Brainstem Pediatric High-Grade Glioma in the HERBY Phase II Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (8) (2020)
Daniel Rodriguez, T Chambers, Monika Warmuth-Metz, E Sanchez Aliaga, D Warren, R Calmon, Darren R Hargrave, Josep Garcia, Gilles Vassal, Jacques Grill, Gudrun Zahlmann, Paul S Morgan, Timothy Jaspan
Evaluation of the Implementation of the Response Assessment in Neuro-Oncology Criteria in the HERBY Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas. AJNR. American journal of neuroradiology 40 (3) (2019)
Selene K Rowe, Daniel Rodriguez, Ellie Cohen, Richard Grundy, Paul S Morgan, Tim Jaspan, Robert A Dineen
Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T1 -Weighted signal increase in deep gray matter of children with brain tumors: A retrospective study. Journal of magnetic resonance imaging : JMRI 51 (1) (2019)